長期投資家のためのIR情報
バリュートレンド

【4506】住友ファーマ
製薬。精神神経、抗がん剤。親会社は住友化学。

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2025.03 2024/10/30 Q2予 338,000 0.0% 0.0% 0 - - - - - - -16,000 0.0% 0.0%
2025.03 2024/07/31 Q1予 338,000 0.0% 0.0% 0 - - - - - - -16,000 0.0% 0.0%
2025.03 2024/05/14 当初予 338,000 - - - 0 - - - - - - - -16,000 - - -
2024.03 2024/05/14 314,558 -0.0% -13.1% -354,859 +0.0% -354.9% - - - - -314,969 +0.0% -293.7%
2024.03 2024/04/29 修正予 314,600 -0.8% -13.1% -354,900 -127.5% -355.0% - - - - -315,000 -123.4% -293.8%
2024.03 2024/01/31 Q3予 317,000 -12.4% -12.4% -156,000 -100.0% -100.0% - - - - -141,000 -76.3% -76.3%
2024.03 2023/10/31 Q2予 362,000 0.0% 0.0% -78,000 0.0% 0.0% - - - - -80,000 0.0% 0.0%
2024.03 2023/07/31 Q1予 362,000 0.0% 0.0% -78,000 0.0% 0.0% - - - - -80,000 0.0% 0.0%
2024.03 2023/05/15 当初予 362,000 - - - -78,000 - - - - - - - -80,000 - - -
2023.03 2023/05/15 555,544 +0.0% +1.0% -76,979 +0.0% -420.7% - - - - -74,512 -0.0% -438.7%
2023.03 2023/04/28 修正予 555,500 -1.3% +1.0% -77,000 -185.2% -420.8% - - - - -74,500 -112.9% -438.6%
2023.03 2023/01/31 Q3予 563,000 -6.8% +2.4% -27,000 +10.0% -212.5% - - - - -35,000 -133.3% -259.1%
2023.03 2022/10/31 修正予 604,000 +9.8% +9.8% -30,000 -225.0% -225.0% - - - - -15,000 -168.2% -168.2%
2023.03 2022/07/29 Q1予 550,000 0.0% 0.0% 24,000 0.0% 0.0% - - - - 22,000 0.0% 0.0%
2023.03 2022/05/13 当初予 550,000 - - - 24,000 - - - - - - - 22,000 - - -
2022.03 2022/05/13 560,035 +0.0% -3.1% 60,234 +0.1% -1.3% - - - - 56,413 +0.0% +37.6%
2022.03 2022/04/28 修正予 560,000 +1.1% -3.1% 60,200 +9.5% -1.3% - - - - 56,400 +52.4% +37.6%
2022.03 2022/01/31 Q3予 554,000 -4.2% -4.2% 55,000 -9.8% -9.8% - - - - 37,000 -9.8% -9.8%
2022.03 2021/10/27 Q2予 578,000 0.0% 0.0% 61,000 0.0% 0.0% - - - - 41,000 0.0% 0.0%
2022.03 2021/07/29 Q1予 578,000 0.0% 0.0% 61,000 0.0% 0.0% - - - - 41,000 0.0% 0.0%
2022.03 2021/05/12 当初予 578,000 - - - 61,000 - - - - - - - 41,000 - - -
2021.03 2021/05/12 515,952 -0.0% +1.2% 71,224 +0.0% +196.8% - - - - 56,219 +0.0% +703.1%
2021.03 2021/04/23 修正予 516,000 +0.2% +1.2% 71,200 +45.3% +196.7% - - - - 56,200 +108.1% +702.9%
2021.03 2021/02/12 修正予 515,000 +1.8% +1.0% 49,000 -15.5% +104.2% - - - - 27,000 -35.7% +285.7%
2021.03 2021/01/28 Q3予 506,000 0.0% -0.8% 58,000 0.0% +141.7% - - - - 42,000 0.0% +500.0%
2021.03 2020/10/28 修正予 506,000 +2.2% -0.8% 58,000 +141.7% +141.7% - - - - 42,000 +366.7% +500.0%
2021.03 2020/07/30 Q1予 495,000 -2.9% -2.9% 24,000 0.0% 0.0% - - - - 9,000 +28.6% +28.6%
2021.03 2020/05/13 当初予 510,000 - - - 24,000 - - - - - - - 7,000 - - -
2020.03 2020/05/13 482,732 +0.0% +4.9% 83,239 +0.0% +20.6% - - - - 40,753 -0.1% -16.8%
2020.03 2020/04/28 修正予 482,700 +1.6% +4.9% 83,200 +10.9% +20.6% - - - - 40,800 +31.6% -16.7%
2020.03 2020/01/30 Q3予 475,000 0.0% +3.3% 75,000 -14.8% +8.7% - - - - 31,000 -13.9% -36.7%
2020.03 2019/10/28 Q2予 475,000 0.0% +3.3% 88,000 0.0% +27.5% - - - - 36,000 0.0% -26.5%
2020.03 2019/07/29 修正予 475,000 +3.3% +3.3% 88,000 +27.5% +27.5% - - - - 36,000 -26.5% -26.5%
2020.03 2019/05/10 当初予 460,000 - - - 69,000 - - - - - - - 49,000 - - -
2019.03 2019/05/10 459,267 -0.0% -1.7% 57,884 -0.0% +9.2% - - - - 48,627 +0.1% +38.9%
2019.03 2019/04/19 修正予 459,300 -1.6% -1.6% 57,900 +9.2% +9.2% - - - - 48,600 +38.9% +38.9%
2019.03 2019/01/31 Q3予 467,000 0.0% 0.0% 53,000 0.0% 0.0% 55,000 0.0% 0.0% 35,000 0.0% 0.0%
2019.03 2018/10/30 Q2予 467,000 0.0% 0.0% 53,000 0.0% 0.0% 55,000 0.0% 0.0% 35,000 0.0% 0.0%
2019.03 2018/07/27 Q1予 467,000 0.0% 0.0% 53,000 0.0% 0.0% 55,000 0.0% 0.0% 35,000 0.0% 0.0%
2019.03 2018/05/11 当初予 467,000 - - - 53,000 - - - 55,000 - - - 35,000 - - -
2018.03 2018/05/11 466,838 -1.5% +3.7% 88,173 +22.5% +60.3% 84,866 +17.9% +54.3% 53,448 -2.8% +48.5%
2018.03 2018/01/30 Q3予 474,000 0.0% +5.3% 72,000 0.0% +30.9% 72,000 0.0% +30.9% 55,000 +17.0% +52.8%
2018.03 2017/10/30 Q2予 474,000 +5.3% +5.3% 72,000 +30.9% +30.9% 72,000 +30.9% +30.9% 47,000 +30.6% +30.6%
2018.03 2017/05/11 当初予 450,000 - - - 55,000 - - - 55,000 - - - 36,000 - - -
2017.03 2017/05/11 411,638 +1.9% +3.4% 52,759 +14.7% +14.7% 54,341 +18.1% +23.5% 28,991 +11.5% +16.0%
2017.03 2017/01/27 Q3予 404,000 +1.5% +1.5% 46,000 0.0% 0.0% 46,000 +4.5% +4.5% 26,000 +4.0% +4.0%
2017.03 2016/10/27 Q2予 398,000 - - - 46,000 - - - 44,000 - - - 25,000 - - -
2016.03 2016/01/27 Q3予 403,000 +0.5% +2.8% 33,000 +13.8% +22.2% 32,500 +14.0% +22.6% 23,000 +15.0% +27.8%
2016.03 2015/10/28 Q2予 401,000 0.0% +2.3% 29,000 +7.4% +7.4% 28,500 +7.5% +7.5% 20,000 +11.1% +11.1%
2016.03 2015/07/29 Q1予 401,000 +2.3% +2.3% 27,000 0.0% 0.0% 26,500 0.0% 0.0% 18,000 0.0% 0.0%
2016.03 2015/05/11 当初予 392,000 - - - 27,000 - - - 26,500 - - - 18,000 - - -
2015.03 2015/05/11 371,370 +0.1% +5.5% 23,275 +16.4% +16.4% 23,331 +16.7% +22.8% 15,447 +23.6% +28.7%
2015.03 2015/01/29 Q3予 371,000 +1.4% +5.4% 20,000 0.0% 0.0% 20,000 +2.6% +5.3% 12,500 -10.7% +4.2%
2015.03 2014/10/30 Q2予 366,000 +4.0% +4.0% 20,000 0.0% 0.0% 19,500 +2.6% +2.6% 14,000 +16.7% +16.7%
2015.03 2014/07/30 Q1予 352,000 0.0% 0.0% 20,000 0.0% 0.0% 19,000 0.0% 0.0% 12,000 0.0% 0.0%
2015.03 2014/05/08 当初予 352,000 - - - 20,000 - - - 19,000 - - - 12,000 - - -
2014.03 2014/05/08 387,693 - - - 42,142 - - - 40,631 - - - 20,060 - - -
ページトップへ戻る